Walgreens appoints new divisional VP, treasurer
DEERFIELD, Ill. Walgreens announced the appointment of Jason Dubinsky as divisional VP and treasurer. Dubinsky, 36, will join Walgreens Aug. 24 from The Goldman Sachs Group in Chicago, where he served as VP investment banking in the division’s consumer retail group.
At Walgreens, Dubinsky will oversee all financing, banking and investing activities for the nation’s largest drugstore chain. Additionally, he will be responsible for corporate risk management and partnering on investor relations matters.
“Jason’s background in both public accounting and investment banking makes him an exceptional choice to lead our treasury department and corporate risk management practice,” said Walgreens president and CEO Greg Wasson. “Jason also brings a strong background in retail, top-notch strategic thinking and creative skills, and a great spirit of collaboration.”
Dubinsky has more than 12 years of finance, accounting and investment experience. He spent the last three years at Goldman Sachs, a $64.5 billion global bank holding company, where he led merger and acquisition transactions, and managed strategic advisory and financing assignments for corporate clients in the retail and consumer sectors. Previously, Dubinsky served as VP investment banking at Lehman Brothers and was with the firm from 2000-2006. Prior to that, he held a senior accountant position with Arthur Andersen in New York.
Dubinsky replaces John Spina, who was promoted last month to Walgreens corporate VP retail integration and new format development.
Stiefel zaps acne segment with ‘leave-on’ treatment
DULUTH, Ga. Stiefel Labs, a GlaxoSmithKline company, launched one of the first “leave-on” treatments for acne care, PanOxyl, as a line extension to the company’s acne-care bar and wash.
The formulation is not greasy as compared with spot treatments, and blends into the skin upon application. The new formulation delivers 10% Benzoyl Peroxide in a foam delivery.
In addition to consumer ad support, Stiefel will be fielding its 200-strong dedicated representatives to detail dermatologists.
Stiefel also introduced its Sensitive Sarna eczema itch relief kit, an all-in-one kit that includes a cleanse, itch relief and moisturizer.
New directors elected to NACDS Foundation board
ALEXANDRIA, Va. The National Association of Chain Drug Stores has elected three new directors to the board of the NACDS Foundation.
Jim VanLieshout, VP retail sales with Apotex; Alice Swearingen, VP channel development sales for GlaxoSmithKline; and Chris Dimos, president of pharmacy operations for Supervalu, will fill vacancies on the board, which consists of 22 members.
“We are pleased to welcome the three new members to the NACDS Foundation board of directors,” said Edith Rosato, president of the NACDS Foundation.
“They will continue the strong representation on the board of chains and suppliers alike. We value their expertise, dedication and commitment to the industry, and we look forward to working together for the good of the public and the patients served by community pharmacy.”